A temporary US ban on exports of critical raw materials could limit the production of coronavirus vaccines by companies such as the Serum Institute of India (SII), its chief executive said in a World Bank panel discussion on Thursday.

Indian vaccine giant SII warns of supply hit from US raw materials export ban

astrazenecaoxford

Astrazeneca/oxford, News on Astrazeneca/oxford, stories on Astrazeneca/oxford, articles on Astrazeneca/oxford, Astrazeneca/oxford stories at Wion, Astrazeneca/oxford news, Astrazeneca/oxford latest news